1.Glass, CK, Witztum, JL. Atherosclerosis. The road ahead. Cell. 2001; 104, 503–516.
2.Amarenco, P, Cohen, A, Tzourio, C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994; 331, 1474–1479.
3.Trzos, E, Uznanska, B, Rechcinski, T, et al. Myocardial infarction in young people. Cardiol J. 2009; 16, 307–311.
4.Tian, N, Penman, AD, Mawson, AR, Manning, RD Jr, Flessner, MF. Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Hypertens. 2010; 4, 272–283.
5.Zoccali, C, Seck, S. What makes plaques vulnerable in CKD?: a fresh look at metalloproteinases. Kidney Int. 2010; 78, 1206–1208.
6.Hackam, DG, Anand, SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003; 290, 932–940.
7.Kavey, RE, Daniels, SR, Lauer, RM, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003; 107, 1562–1566.
8.Leduc, L, Levy, E, Bouity-Voubou, M, Delvin, E. Fetal programming of atherosclerosis: possible role of the mitochondria. Eur J Obstet Gynecol Reprod Biol. 2010; 149, 127–130.
9.Libby, P, Ridker, PM, Maseri, A. Inflammation and atherosclerosis. Circulation. 2002; 105, 1135–1143.
10.Hansson, GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352, 1685–1695.
11.Stary, HC, Blankenhorn, DH, Chandler, AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Circulation. 1992; 85, 391–405.
12.Barker, DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998; 95, 115–128.
13.McGill, HC Jr, McMahan, CA, Herderick, EE, et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000; 72 (Suppl 5), 1307S–1315S.
14.Palinski, W, Napoli, C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002; 16, 1348–1360.
15.Goharkhay, N, Sbrana, E, Gamble, PK, et al. Characterization of a murine model of fetal programming of atherosclerosis. Am J Obstet Gynecol. 2007; 197, e411–e415.
16.Knackstedt, MK, Hamelmann, E, Arck, PC. Mothers in stress: consequences for the offspring. Am J Reprod Immunol. 2005; 54, 63–69.
17.Pincus-Knackstedt, MK, Joachim, RA, Blois, SM, et al. Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation. J Immunol. 2006; 177, 8484–8492.
18.Andersson, IJ, Jiang, YY, Davidge, ST. Maternal stress and development of atherosclerosis in the adult apolipoprotein E-deficient mouse offspring. Am J Physiol Regul Integr Comp Physiol. 2009; 296, R663–R671.
19.Paigen, B, Morrow, A, Holmes, PA, Mitchell, D, Williams, RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68, 231–240.
20.Dickhout, JG, Lhoták, Š, Hilditch, BA, et al. Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. FASEB J. 2011; 25, 576–589.
21.Solovjov, DA, Pluskota, E, Plow, EF. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem. 2005; 280, 1336–1345.
22.Leenen, PJ, de Bruijn, MF, Voerman, JS, Campbell, PA, van Ewijk, W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods. 1994; 174, 5–19.
23.Davignon, D, Martz, E, Reynolds, T, Kurzinger, K, Springer, TA. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc Natl Acad Sci. 1981; 78, 4535–4539.
24.Whitman, SC. A practical approach to using mice in atherosclerosis research. Clin Biochem Rev. 2004; 25, 81–93.
25.Kiecolt-Glaser, JK, Glaser, R, Gravenstein, S, Malarkey, WB, Sheridan, J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci. 1996; 93, 3043–3047.
26.Kop, WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med. 1999; 61, 476–487.
27.Everson, SA, Lynch, JW, Chesney, MA, et al. Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ. 1997; 314, 553–558.
28.Kaplan, JR, Manuck, SB, Clarkson, TB, Lusso, FM, Taub, DM. Social status, environment, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis. 1982; 2, 359–368.
29.Chen, E, Hanson, MD, Paterson, LQ, et al. Socioeconomic status and inflammatory processes in childhood asthma: the role of psychological stress. J Allergy Clin Immunol. 2006; 117, 1014–1020.
30.Hansson, GK, Hermansson, A. The immune system in atherosclerosis. Nat Immunol. 2011; 12, 204–212.
31.Nakashima, Y, Raines, EW, Plump, AS, Breslow, JL, Ross, R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998; 18, 842–851.
32.Blois, S, Tometten, M, Kandil, J, et al. Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J Immunol. 2005; 174, 1820–1829.